KayoThera

KayoThera leverages cutting-edge discoveries to develop therapeutics for cancer patients who currently receive terminal diagnoses. Two pipeline candidates target novel biology to deplete immuno-suppressive cells from solid tumors and inhibit tumor survival mechanisms in advanced cancers. With these first-in-class, orally available small molecule therapeutics, Kayothera aims to give hope to patients with intractable cancers.